Current public status

As of the March 2026 review reflected on this site, the public pages include a manual email route for clinic representatives but do not present an active paid-placement programme or a self-serve commercial product. This page exists so the rules are visible before any paid rollout, not after the fact.

Neutral baseline first

The baseline directory record is built from public sources and platform standards. It should remain readable as a neutral profile even if the platform later offers paid products.

Possible commercial formats

Claimed listing
A verified business representative may be able to manage selected business-supplied fields, while platform-controlled facts and labels stay under platform control.
Enhanced profile
A business may be allowed to add extra supplied material or richer presentation, provided it is labelled clearly and does not masquerade as neutral verification.
Featured placement
A business may be given additional visibility in a clearly labelled promotional placement. That visibility is not the same thing as endorsement or regulatory approval.

What commercial status cannot buy

  • No regulator-style badges, “approved clinic” wording, or disguised trust marks.
  • No purchase of review dates, authority links, or neutral source-basis notes.
  • No suppression of relevant public-source uncertainty or gaps.
  • No suggestion that payment proves clinical quality, safety, or medical suitability.

How disclosure should appear

If commercial features go live, a reasonable reader should be able to distinguish them immediately from the neutral directory baseline. Labels should be plain, visible, and not buried in fine print.

Commercial visibility and neutral inclusion are separate questions. A clinic can appear in the baseline directory without paying, and a clinic paying for a promotional feature still should not be presented as endorsed.

Labelling expectations for paid or enhanced features

Whenever money changes hands for visibility or upgraded presentation, we expect:

  • On-profile labels — each affected clinic profile (or section of it) should show plain wording that the relevant block is commercial, enhanced, sponsored, or otherwise paid — whichever term matches the product.
  • List and search context — if a clinic appears higher or more prominently because of payment, that placement should carry the same class of label in the list or map context, not only on the profile.
  • No “soft” disclosure — disclosure should not rely on a one-off site-wide footnote while the profile itself reads like a neutral editorial pick.
  • Stability — if a paid term ends, visibility and labels should revert without implying a past promotional period was neutral endorsement.

Current stance: no display advertising and no active paid-placement programme on the public site as of the last review noted on relevant pages. Clinic enquiries, corrections, public-source updates, and future listing questions currently start by email and are reviewed manually. Future products should follow this page and the Terms of Use.

Relationship to field control

The platform’s field-control model is explained on Methodology. Commercial features, where offered, affect visibility or optional business-supplied material, not the integrity rules around public-source fields.

Transparency note

Public email for enquiries: support@peptideclinicguide.co.uk. Clinic enquiries, corrections, commercial questions, and public-source updates are handled by email and reviewed manually.